BAE: Bovine aortic endothelial; RHP: Recombinant human protein. NSAIDs variably inhibit prostaglandin H synthase (COX). COX-2 was cloned in 1991, and it was subsequently established that COX-1 does ...
The cyclooxygenase-2 (COX-2) selective nonsteroidal anti-inflammatory drugs (NSAIDs) celecoxib (Celebrex) and rofecoxib (Vioxx) were first listed on the Ontario Drug Benefit (ODB) formulary as ...
Augusta University has patented NSAID derivatives acting as prostaglandin G/H synthase 1 (PTGS1; COX-1) and/or COX-2 inhibitors potentially useful for the treatment of inflammation and pain.
Bethesda, Maryland (Feb. 2, 2006) – According to two studies published today in the American Gastroenterological Association (AGA) journal Clinical Gastroenterology and Hepatology, prescription ...
The recent proton pump inhibitor studies with omeprazole indicate that this class of drugs is efficacious in the prophylaxis of NSAID-induced ulceration (and hence presumably ulcer complications, ...
NEW YORK (Reuters Health) - Although all of the common strategies protect the upper gastrointestinal tract from the complications of nonsteroidal anti-inflammatory drugs (NSAIDs), popular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results